Detalles de la búsqueda
1.
Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer.
J Clin Oncol;
: JCO2301237, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38743911
2.
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
Eur J Cancer;
202: 114001, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38489858
3.
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
Eur J Cancer;
201: 113923, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377775
4.
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.
Clin Cancer Res;
30(4): 741-753, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38051741
5.
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development.
J Natl Cancer Inst;
116(2): 200-207, 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37975877
6.
Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer - An ACCELERATE Multistakeholder Consensus.
Clin Pharmacol Ther;
115(1): 36-41, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37885401
7.
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed.
J Clin Oncol;
42(3): 253-257, 2024 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011605
8.
The organization of care in pediatric radiotherapy across SIOP Europe affiliated centers: A multicenter survey in the framework of the 'Joint Action on Rare Cancers' project.
Radiother Oncol;
191: 110075, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38159681
9.
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial.
Nat Med;
29(12): 2985-2987, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37857712
10.
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial.
Eur J Cancer;
191: 112984, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37549532
11.
Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study.
JAMA Netw Open;
6(7): e2321568, 2023 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399010
12.
Predictive factors of long-term follow-up attendance in very long-term childhood cancer survivors.
Cancer;
129(21): 3476-3489, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432135
13.
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer;
190: 112950, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441939
14.
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis.
JCO Precis Oncol;
7: e2200651, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37384865
15.
Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models.
Front Oncol;
13: 1166063, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37377921
16.
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.
J Clin Oncol;
41(18): 3408-3422, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37015036
17.
Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions.
Expert Opin Drug Metab Toxicol;
19(2): 75-90, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36939456
18.
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.
Oncologist;
28(5): e242-e253, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36961477
19.
Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children and adolescents.
Lancet Child Adolesc Health;
7(3): 214-222, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36682367
20.
Changing incentives to ACCELERATE drug development for paediatric cancer.
Cancer Med;
12(7): 8825-8837, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645217